NCT00354250
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
- Locations
-
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
Clinical trial condition
Kidney Neoplasms
Explore clinical trials studying Kidney Neoplasms. Study availability and eligibility vary by location and protocol.
1,164 public trials
220 recruiting studies
Kidney Neoplasms trial results
NCT00045006
- Conditions
- Adenocarcinoma, Adnexal Diseases, Blood Protein Disorders, +110 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT00944905
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +22 more
- Locations
-
- Yale University School of Medicine New Haven, Connecticut, United States
- Emory University Winship Cancer Center Atlanta, Georgia, United States
- The University of Chicago Chicago, Illinois, United States
- University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States
NCT01381601
- Conditions
- Adenocarcinoma, Behavior, Behavioral Symptoms, +17 more
- Locations
-
Not specified
NCT01381614
- Conditions
- Adenocarcinoma, Behavior, Behavioral Symptoms, +17 more
- Locations
-
Not specified
NCT00217542
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +27 more
- Locations
-
- Yale University New Haven, Connecticut, United States
Completed
Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors
NCT00112476
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +27 more
- Locations
-
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
Completed
Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors
NCT00089362
- Conditions
- Adenocarcinoma, Adnexal Diseases, Breast Diseases, +142 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
NCT00569283
- Conditions
- Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +110 more
- Locations
-
- Korea Research Institute of Bioscience and Biotechnology Dajeon, South Korea
- Asan Medical Center - University of Ulsan College of Medicine Seoul, South Korea
Completed
Ixabepilone in Treating Patients With Metastatic, Recurrent, or Unresectable Kidney Cancer
NCT00182702
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
- Locations
-
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States